Touchlight wins prestigious Lloyds Bank National Business Award

Hampton, UK – 11 November 2020 – Touchlight was announced the winner of The LDC Growth Through Innovation Award at the prestigious 2020 Lloyds Bank National Business Awards, which took place during an online ceremony on 10 November.

Commenting on the awards, Jonny Ohlson, Founder and Executive Chairman of Touchlight, said:

“It is a privilege to receive this award on behalf of the Touchlight team. After a transformative year for the Company, we’re delighted to have won the LDC Growth Through Innovation Award.

“Vaccines have been in the limelight this year, and we are grateful to Lloyds Bank National Business Awards for recognizing our commitment and our innovative dbDNA technology in helping develop and deliver vital vaccines across the globe.”

The Judges of the LDC Growth Through Innovation Award commented on Touchlight:

“Super innovative, pioneering, disruptor – a team of game changers.”

Sarah Austin, Awards Director, added:

“2020 has been a challenging but inspiring year; a year where we’ve witnessed just how innovative and adaptive the UK business community can be, whether that means helping employees adjust to new ways of working or shifting production towards masks, ventilators and handwash. This year’s winners are testament to the creativity, agility and resilience that sets British business apart.”

About the National Business Awards
Open to organisations of all sizes from all sectors across the UK, the Lloyds Bank National Business Awards programme is the UK’s most prestigious independent business recognition platform with particular emphasis on excellence, innovation and ethical business. Now in their 19^th year, the Lloyds Bank National Business Awards connect the nation’s professionals through this annual awards ceremony, year-round thought leadership and round table events. Visit www.nationalbusinessawards.co.uk for further information or follow us on Twitter @businessawards.

The Lloyds Bank National Business Awards is organised by Informa Markets, a division of Informa plc – a leading B2B information services group and the largest B2B Events organiser in the world.

- ENDS -

About Touchlight

Touchlight is a privately-owned CDMO based in London, U.K., focused on the provision of DNA services and manufacture of enzymatically produced doggybone DNA (dbDNA™) to enable the development of genetic medicines. Touchlight provide rapid, enzymatic DNA development and manufacturing for all advanced therapy production, including mRNA, viral and non-viral gene therapy and DNA API. dbDNA is a minimal, linear, covalently closed structure, which eliminates bacterial sequences. Touchlight’s revolutionary enzymatic production platform enables unprecedented speed, scale, and the ability to target genes with a size and complexity that is impossible with current technologies. Clients can be supported from pre-clinical through development and supply, to licencing and tech transfer for use in-house.

For more information please contact: